Individual pathogens, pathogen burden and markers of subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis

Journal of Cardiovascular Medicine

Volumn 10, Issue 10, 2009, Pages 747-751

  Szklo, Moyses ^a   Ding, Jingzhong ^b   Tsai, Michael Y ^c   Cushman, Mary ^d   Polak, Joseph F ^e   Lima, João ^f   Barr, R Graham ^g   Sharrett, A Richey ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Atherosclerosis; infections; pathogens

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; HIGH DENSITY LIPOPROTEIN; INTERCELLULAR ADHESION MOLECULE 1; VIRUS ANTIBODY;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CAROTID ARTERY; CHLAMYDOPHILA PNEUMONIAE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; RANDOM SAMPLE; SMOKING; STATISTICAL SIGNIFICANCE;

AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ATHEROSCLEROSIS; CALCIUM; CAROTID ARTERIES; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; ETHNIC GROUPS; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; VIRAL LOAD;

EID: 70349158696     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32832cacab     Document Type: Article

References (36)

1. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med 1978; 148:335-340.
2. Li L, Messas E, Batista EL Jr, Levine RA, Amar S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 2002; 105:861-867.
3. Nieto FJ. Viruses and atherosclerosis: a critical review of the epidemiologic evidence. Am Heart J 1999; 138:S453-S460.
4. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Comstock GW, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996; 94:922-927.
5. Sorlie PD, Adam E, Melnick SL, Folsom A, Skelton T, Chambless LE, et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol 1994; 42:33-37.
6. Ibrahim AI, Obeid MT, Jouma MJ, Moasis GA, Al-Richane WL, Kindermann I, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein- Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 2005; 32:29-32.
7. Zhu J, Quyyumi AA, Norman JE, Costello R, Csako G, Epstein SE. The possible role of hepatitis A virus in the pathogenesis of atherosclerosis. J Infect Dis 2000; 182:1583-1587.
8. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45:1219-1222.
9. Nieto FJ, Folsom AR, Sorlie PD, Grayston JT, Wang SP, Chambless LE. Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 1999; 150:149-156.
10. Huittinen T, Leinonen M, Tenkanen L, Virkkunen H, Mänttäri M, Palosuo T, et al. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 2003; 107:2566-2570.
11. Beck JD, Pankow J, Tyroler HA, Offenbacher S. Dental infections and atherosclerosis. Am Heart J 1999; 138:S528-S533.
12. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 2000; 20:1417-1420.
13. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002; 33:2581-2586. (Pubitemid 35266427)
14. Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000; 85:140-146.
15. Zhu J, Nieto FJ, Horne BD, Anderson JL, Muhlestein JB, Epstein SE. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001; 103:45-51.
16. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus with immune reactions to heatshock protein 60 and carotid or femoral atherosclerosis. Circulation 2000; 102:833-839.
17. Grundy JE, Downes KL. Up-regulation of LFA-3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus. Immunology 1993; 78:405-412.
18. Hajjar DP, Fabricant CG, Minick CR, Fabricant J. Virus-induced atherosclerosis. Herpes virus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 1986; 122:62-70.
19. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice - a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107:499-511.
20. Rott D, Zhu J, Burnett MS, Zhou YF, Wasserman A, Walker J, et al. Serum of cytomegalovirus-infected mice induces monocyte chemoattractant protein- 1 expression by endothelial cells. J Infect Dis 2001; 184:1109-1113.
21. Zhou YF, Yu ZX, Wanishsawad C, Shou M, Epstein SE. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun 1999; 256:608-613.
22. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, et al. Multiethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002; 156:871-881.
23. Carr JJ, Nelson JC, Wong ND, McNitt-Gray M, Arad Y, Jacobs DR Jr, et al. Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. Radiology 2005; 234:35-43.
24. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:827-832.
25. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340:14-22.
26. Kim DK, Kim HJ, Han SH, Lee JE, Moon SJ, Kim BS, et al. Chlamydia pneumoniae accompanied by inflammation is associated with the progression of atherosclerosis in CAPD patients: a prospective study for 3 years. Nephrol Dial Transplant 2008; 23:1011-1018.
27. Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol Infect 1998; 120:93-99.
28. Luchsinger JA, Pablos-Méndez A, Knirsch C, Rabinowitz D, Shea S. Relation of antibiotic use to risk of myocardial infarction in the general population. Am J Cardiol 2002; 89:18-21.
29. Andraws R, Berger JS, Brown DL. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 2005; 293:2641-2647.
30. Rupprecht HJ, Blankenberg S, Bickel C, Rippin G, Hafner G, Prellwitz W, et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001; 104:25-31.
31. Kis Z, Sas K, Gyulai Z, Treso B, Petrovay F, Kapusinszky B, et al. Chronic infections and genetic factors in the development of ischemic stroke. New Microbiol 2007; 30:213-220.
32. Bloemenkamp DG, Mali WP, Tanis BC, Rosendaal FR, van den Bosch MA, Kemmeren JM, et al. Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women. Atherosclerosis 2002; 163:149-156.
33. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002; 106:184-190.
34. Hagiwara N, Toyoda K, Inoue T, Shimada H, Ibayashi S, Iida M, et al. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients. J Stroke Cerebrovasc Dis 2007; 16:145-152.
35. Khairy P, Rinfret S, Tardif JC, Marchand R, Shapiro S, Brophy J, et al. Absence of association between infectious agents and endothelial function in healthy young men. Circulation 2003; 107:1966-1971.
36. Ridker PM, Hennekens CH, Buring JE, Kundsin R, Shih J. Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women. Ann Intern Med 1999; 131:573-577.